Judith C Lin MD
Clotting Disorder, Hemophilia & Bleeding Disorder
Assistant Professor
Join to View Full Profile
800 Rose St Roach Cancer Ctr 1st FLLexington, KY 40536
Phone+1 859-257-6006
Fax+1 859-257-6002
Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterPost-Doctoral Fellowship, 1999 - 2005
Orthopaedic Institute for ChildrenPost-Doctoral Fellowship, 1997 - 1998
University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 1995 - 1997- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1992 - 1995
Stony Brook University Health Sciences Center School of MedicineClass of 1992- Massachusetts Institute of TechnologySB & SB, Chemistry & Life Science
Certifications & Licensure
CA State Medical License 1993 - 2027
KY State Medical License 2024 - 2026
NY State Medical License 1993 - 2026
MA State Medical License 1999 - 2024
ME State Medical License 2022 - 2023
WA State Medical License 2019 - 2022
OR State Medical License 2019 - 2021
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
Publications & Presentations
PubMed
- 55 citationsRecombinant factor VIIa analog in the management of hemophilia with inhibitors: Results from a multicenter, randomized, controlled trial of vatreptacog alfaSteven R. Lentz, Silke Ehrenforth, F. Abdul Karim, Tadashi Matsushita, K. N. Weldingh
Journal of Thrombosis and Haemostasis. 2014-08-01 - 8 citationsPatient characteristics that influence efficacy of prophylaxis with rFVIII‐FS three times per week: a subgroup analysis of the LIPLONG studyShadan Lalezari, A. Coppola, J. C. Lin, Monika Maas Enriquez, D. Tseneklidou-Stoeter
Haemophilia. 2014-05-01 - 129 citationsPhase I study of BAY 94‐9027, a PEGylated B‐domain‐deleted recombinant factor VIII with an extended half‐life, in subjects with hemophilia AT. E. Coyle, Mark T. Reding, J. C. Lin, L. A. Michaels, A. Shah
Journal of Thrombosis and Haemostasis. 2014-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
